AzTrials
AzTrials

InsomniaSHUTi-DCNCT07836491

Web-Based Insomnia Treatment for Spousal Dementia Caregivers (SHUTi-DC)

A study testing SHUTi-DC and PE in people with Insomnia, run by University of Missouri-Columbia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Many people who care for a husband or wife with Alzheimer's disease or another dementia have trouble sleeping. About 40 to 60 out of every 100 spousal caregivers have insomnia, which means trouble falling asleep, trouble staying asleep, or waking up too early. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Insomnia
What is being tested?
SHUTi-DC and PE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
1 Jan 2027to 31 May 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Spousal caregiver of a person with a clinician-diagnosed Alzheimer's disease or related dementia, with both partners cohabiting in the community
  • Clinically meaningful insomnia symptoms, defined as an Insomnia Severity Index (ISI) score of 8 or higher
  • Regular internet access and ability to independently use a computer or smartphone
  • Fluent in English
  • Residing within the United States

Who cannot join

  • Parasomnia symptoms, including dream enactment or injurious nocturnal behaviors suggestive of REM sleep behavior disorder
  • Night-shift work, indicating primary circadian misalignment rather than insomnia
  • Current behavioral or psychological treatment for insomnia
  • Severe psychiatric conditions, such as current mania or hypomania, that would interfere with participation or safety
  • Significant cognitive impairment in the caregiver that would limit ability to engage in study procedures
  • Medical conditions that substantially affect sleep or safety, including neurodegenerative disease, stroke, traumatic brain injury, epilepsy, severe respiratory disease, pregnancy, or breastfeeding
  • Sleep difficulties fully attributable to caregiving tasks without underlying insomnia mechanisms

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Eunjin Tracy, PhD contact

3852454212

eunjintracy@missouri.edu

About this study

Official title: Mechanisms of Action, Efficacy, and Feasibility of a Web-Based Cognitive Behavioral Therapy for Insomnia Intervention in Spousal Alzheimer's Disease and Related Dementias Caregivers

Many people who care for a husband or wife with Alzheimer's disease or another dementia have trouble sleeping. About 40 to 60 out of every 100 spousal caregivers have insomnia, which means trouble falling asleep, trouble staying asleep, or waking up too early. Poor sleep can make it harder to handle stress, think clearly, and stay healthy.

Cognitive behavioral therapy for insomnia, or CBT-I, is the recommended treatment for insomnia. It helps people change the habits and thoughts that keep them awake. But CBT-I is hard for caregivers to get. There are not enough trained therapists, and caregivers often cannot leave home for appointments.

Read more

This study tests an online program called SHUTi-DC. It delivers CBT-I over the internet, so caregivers can use it at home whenever it fits their schedule. The program was adapted for people caring for a spouse with dementia.

The study will enroll 80 spousal caregivers who have insomnia symptoms. Half will be assigned to SHUTi-DC, which has eight weekly online modules that take 20 to 40 minutes each. The other half will receive a web-based sleep education program with general information about sleep health. A computer decides which program each person receives, similar to flipping a coin.

Everyone will answer questions about their sleep and well-being at the start of the study, each week during the program, and again six weeks after the program ends.

The researchers want to find out whether SHUTi-DC improves insomnia symptoms, how it works, and whether caregivers find the program helpful and easy to use.

Conditions
Insomnia
Being tested
SHUTi-DC, PE
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SHUTi-DCBehavioural

    Also called Sleep Healthy Using the Internet for Dementia Caregivers

    An adapted, self-paced, web-based cognitive behavioral therapy for insomnia program for spousal ADRD caregivers. The program includes eight modules: six standard SHUTi CBT-I modules covering sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, and relapse prevention, plus two psychoeducational modules with dementia-specific content addressing dementia education, disease progression, caregiving routines, and heightened vigilance. Modules are asynchronous and completed over an eight-week period, with each 20 to 40 minute session unlocking weekly to encourage metered participation. Participants complete daily online sleep diaries that generate tailored sleep schedule recommendations.

  • PEBehavioural

    Also called Patient Education

    An active control condition providing online sleep health information. Materials cover content similar to SHUTi, including insomnia prevalence and causes and basic strategies to reduce insomnia symptoms, but are simpler and primarily text-based and no interactive or video-based elements. All content is delivered at once rather than unlocking weekly. Participants also receive the adapted portions of Module 1 and Module 8 containing dementia-specific content tailored for spousal ADRD caregivers.

Study groups in NCT07836491
Study groupRoleWhat they receive
SHUTi-DCExperimentalParticipants receive SHUTi-DC, an adapted version of the Sleep Healthy Using the Internet program consisting of eight weekly interactive online modules: six standard cognitive behavioral therapy for insomnia modules plus two dementia-specific modules. Each module takes 20 to 40 minutes.
Receives: Behavioral: SHUTi-DC
Patient Education (PE)Active comparatorOnline sleep health education delivered as static text-based content in a single release, plus two adapted modules addressing the dementia caregiving context.
Receives: Behavioral: PE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Insomnia Severity Index (ISI) score

    The Insomnia Severity Index assesses the nature, severity, and impact of insomnia. Scores of 8 or above indicate clinically significant insomnia symptoms.

    Measured: Baseline, weekly during the intervention period, and at a post-intervention follow-up conducted 6 weeks after the intervention ends

Secondary outcomes (2)
  1. Change in sleep efficiency

    Sleep efficiency is derived from the 11-item Consensus Sleep Diary, completed daily by participants in both conditions throughout the intervention period.

    Measured: During the 8-week intervention period

  2. Change in Pre-Sleep Arousal Scale (PSAS) score

    The Pre-Sleep Arousal Scale is a 16-item self-report measure of cognitive and somatic arousal at bedtime, completed by participants in both conditions.

    Measured: During the 8-week intervention period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2026
  2. Study start1 Jan 2027 (estimated)
  3. Primary completion28 Feb 2028 (estimated)
  4. Study completion31 May 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07836491
Sponsor's protocol ID
2133987
Other IDs
P30AG086642
Acronym
SHUTi-DC
Status last verified
Sep 2026
First submitted
17 Sep 2026
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying published results will be made available to qualified researchers. The dataset will include demographic and clinical characteristics, daily sleep diary data, weekly survey data, and outcome measures, together with a data dictionary. Direct identifiers will be removed and indirect identifiers will be modified or aggregated as needed to protect participant confidentiality, consistent with the informed consent under which data were collected.

Questions about this trial

What is this clinical trial studying?

A study testing SHUTi-DC and PE in people with Insomnia, run by University of Missouri-Columbia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eunjin Tracy, PhD (3852454212, eunjintracy@missouri.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Insomnia Severity Index (ISI) score (time frame: Baseline, weekly during the intervention period, and at a post-intervention follow-up conducted 6 weeks after the intervention ends). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in